FG
DBD

Formula Growth’s Diebold Nixdorf Incorporated DBD Stock Holding History

Formula Growth’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-152,217
Closed -$1.38M – 154
2021
Q4 		$1.38M Sell
152,217
-41,780
-22% -$388K 0.24% 104
2021
Q3 		$1.96M Hold
193,997
– – 0.28% 99
2021
Q2 		$2.49M Buy
193,997
+56,642
+41% +$777K 0.34% 91
2021
Q1 		$1.94M Sell
137,355
-218,522
-61% -$3.01M 0.28% 106
2020
Q4 		$3.79M Sell
355,877
-3,771
-1% -$34.3K 0.63% 41
2020
Q3 		$2.75M Sell
359,648
-388,795
-52% -$2.86M 0.51% 55
2020
Q2 		$4.54M Buy
748,443
+330,000
+79% +$1.63M 0.77% 37
2020
Q1 		$1.47M Buy
+418,443
New +$3.54M 0.28% 78
2018
Q3 		– Sell
-510,000
Closed -$6.09M – 158
2018
Q2 		$6.09M Buy
510,000
+100,000
+24% +$1.34M 0.67% 44
2018
Q1 		$6.31M Buy
410,000
+135,000
+49% +$2.25M 0.75% 40
2017
Q4 		$4.5M Buy
+275,000
New +$5.32M 0.59% 46
2017
Q1 		– Sell
-192,279
Closed -$4.84M – 155
2016
Q4 		$4.84M Buy
+192,279
New +$4.53M 1.12% 23

Other funds holding DBD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Formula Growth's DBD Position: Q1 2022 in Review

Formula Growth sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2022, closing a stake of 152,217 shares — an estimated $1.38M sold.

Formula Growth first reported a position in DBD in Q4 2016 and held it in 12 quarters. The position peaked at $6.31M in Q1 2018. 184 funds tracked by Wall St. Rank hold DBD as of Q1 2022.

  • Formula Growth reported no remaining Diebold Nixdorf Incorporated position as of Q1 2022 after selling out during the quarter.
  • Formula Growth sold 152,217 Diebold Nixdorf Incorporated shares in Q1 2022, an estimated $1.38M.
  • Formula Growth first reported a position in Diebold Nixdorf Incorporated in Q4 2016 and held it in 12 quarters.
  • Formula Growth's Diebold Nixdorf Incorporated position peaked at $6.31M in Q1 2018.
  • 184 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2022.

Based on Formula Growth's 13F filing for Q1 2022, filed 13 May 2022.